Compound Churna combines two or more herbs in classical fixed ratios, unlike single herb churna. A guide for B2B buyers on composition, quality, and sourcing.
Compound Churna is an Ayurvedic powder formulation that combines two or more herbs in a fixed ratio defined by classical texts such as Sharangdhar Samhita and Bhaishajya Ratnavali. Unlike single herb churna, a compound formulation integrates multiple botanical ingredients with specific ratio requirements, making ingredient sourcing, ratio accuracy, and blending consistency the primary quality concerns for any B2B buyer sourcing at scale.
Churna, as a dosage form, refers to a finely powdered preparation of one or more dried plant parts. When a single plant material is powdered alone, the product is a single herb churna. When two or more ingredients are combined in proportions specified by classical texts, the result is compound churna, known in classical literature as Mishra Churna or Yoga Churna. The proportions are not arbitrary: they are defined in classical formularies and have been standardised for commercial manufacture in the Ayurvedic Formulary of India and the Ayurvedic Pharmacopoeia of India.
Raasa Ayurveda's portfolio includes mixed churna formulations across 32 classical preparations, each produced to classical ratios. The category sits alongside 31 single herb churna in a broader powdered herb range. For a B2B buyer, understanding the distinction between these two sub-categories matters because the quality assurance requirements, the incoming material controls, and the shelf-life management practices differ between them.
The most important difference is the ratio requirement. A single herb churna has one variable: the quality and particle size of a single plant material. A compound churna has as many quality variables as it has ingredients, plus the ratio between them. If a manufacturer substitutes a lower-grade ingredient or adjusts a ratio because of supply constraints without informing the buyer, the finished product can still look and smell similar while delivering a different formulation profile.
For a buyer procuring single herb churna, the COA focuses on identity, purity, ash values, and microbial limits for a single plant material. For compound churna, the COA should additionally confirm the ingredient proportions, either by referencing the classical formula or by including assay values for marker compounds where pharmacopoeial monographs exist. Ask the supplier how they verify ratio consistency between batches. The most reliable approach is to test marker compounds specific to individual ingredients so that the relative contribution of each can be tracked.
Particle size is another variable that matters more in compound churna. When multiple plant materials with different densities and moisture contents are combined and milled together, the resulting blend can segregate during handling and transport if particle size distribution is not tightly controlled. Ask the supplier what mesh specification is used and whether the blend is tested for uniformity before packaging.
The primary classical sources for compound churna formulations are Sharangdhar Samhita (13th century), Bhaishajya Ratnavali, and Chakradatta. These texts specify ingredient lists and ratios for a large number of compound powders that remain in commercial production today. The Ayurvedic Formulary of India, published under the authority of the Ministry of AYUSH, provides standardised monographs for many of these formulations and is the reference most often cited in regulatory submissions and GMP compliance documentation.
For buyers sourcing compound churna for markets outside India, it is worth confirming that the supplier can reference AFI monographs in their technical documentation. Several importing countries and institutional buyers require that classical formulations be traceable to a recognised pharmacopoeial standard rather than a proprietary specification. This traceability simplifies import clearance and reinforces product credibility in regulated markets.
The standard quality tests for compound churna under GMP and pharmacopoeial requirements include: loss on drying (moisture content), total ash and acid-insoluble ash, heavy metal screen, microbial limit tests (total viable aerobic count, yeast and mould count, and absence of specified pathogens), and particle size distribution. Where the Ayurvedic Pharmacopoeia of India specifies marker compound assay values for a particular formulation, these should also appear in the certificate of analysis.
From a practical standpoint, buyers should request that the COA reference the batch number, manufacturing date, and retest date. For blended preparations, the COA should also identify the ingredient lots used in the batch, particularly where a single ingredient dominates the formulation and its quality has a disproportionate effect on the finished product. Confirming that the supplier retains reference samples from each batch is also good practice, as these become important if a dispute about product quality arises after delivery.
For a first-time order, request a sample from the intended batch rather than from a demonstration lot prepared separately. Test it against the supplier's COA and, if possible, against the AFI or API reference specification. If the initial results satisfy your quality requirements, negotiate a supply arrangement that specifies the classical reference formula, the mesh size, the retest period, and the packaging format in writing. Unspecified parameters tend to drift between batches if they are not explicitly agreed upon.
For repeat orders, maintain your own reference sample archive against which each new delivery can be compared. A simple organoleptic check, covering colour, odour, texture, and flow properties, combined with a basic moisture and ash check, can catch most batch-to-batch problems before they reach your production or retail floor. For higher-stakes formulations, commission periodic third-party testing at an NABL-accredited laboratory to provide independent confirmation of consistency.
To discuss classical mixed churna supply requirements, including formulation specifications, sample requests, and batch documentation, contact Raasa Ayurveda in Kanpur. Our facility operates under AYUSH manufacturing licence A-4177/2009 and GMP certificate D-5755/09, covering 32 compound churna formulations as part of a 339-formulation classical range. Reach the team via bulk supply at +91 9415128217 or raasaayurveda@gmail.com.
Single herb churna is the powdered form of one plant material. Compound churna, also called Mishra Churna, combines two or more ingredients in ratios defined by classical texts such as Sharangdhar Samhita or Bhaishajya Ratnavali. The compound form has more quality variables, including ratio accuracy and particle size uniformity across multiple ingredients.
Ask the supplier to reference the Ayurvedic Formulary of India monograph for the specific preparation and confirm the ingredient ratios used. Where pharmacopoeial marker compound assays exist, request that these appear in the certificate of analysis. Retain reference samples for comparison across repeat batches to monitor consistency over time.
Yes. Any compound churna sold commercially as an Ayurvedic drug must be manufactured under Schedule T GMP conditions and under a valid AYUSH manufacturing licence. The manufacturer should be able to produce both documents on request. GMP compliance covers the blending process, ingredient traceability, batch records, and finished-product testing.
The Ayurvedic Pharmacopoeia of India specifies mesh requirements for individual preparations, most commonly in the range of 80 to 120 mesh. Confirm the mesh specification for the specific formulation you need before placing a bulk order. Particle size consistency matters for blend uniformity and can affect how the product performs in downstream encapsulation or tableting processes.
Raasa Ayurveda, 49/72-A, Naughara, Kanpur 208001, Uttar Pradesh, India. Telephone +91 9415128217. Email raasaayurveda@gmail.com.